IP Knowledge BankYoung Innovators › Uma Sthanu
Global · Health & Accessibility

Uma Sthanu: Research into Regenerating Damaged Neurons

Research into Regenerating Damaged Neurons.

WhereTX, USA
When2025
Age at the work17
IP outcomeNo public IP record found

Image: Society for Science media kit (credit line mandatory)

Uma Sthanu investigated whether regulating prostaglandin E2 could support the regeneration of damaged neurons. Using laboratory techniques to study the response of injured brain cells, she explored a therapeutic direction relevant to neurological injury and disease. The project remains research rather than a patient-ready treatment, but its question is ambitious and medically important.

Innovation mindset: A challenge can be enormous—such as damaged neurons that do not readily regrow—while the experiment remains precise, testable and focused on one biological pathway.

Official project title: Paving the Path to the Impossible: Regenerating Neurons Using Prostaglandin E2 Regulation as a Therapeutic Strategy (Biomedical and Health Sciences). Research-stage; not a treatment.

IP note

No public IP record; any filing made around the May 2025 fair would not yet be published under the 18-month rule — register check due from late 2026.

Recognition

Regeneron ISEF 2025 — First Award ($6,000); Mary Sue Coleman Award for Life Science Innovation & Impact ($10,000).

What this means for a student inventor in India

[Editor: 120–200 words connecting this story to the Indian route — Section 6 (any true inventor may apply), provisional vs complete specification, disclosure at fairs (Section 31), renewals, and who owns what when a school is involved. Link to the relevant MYCrave guide.]

Related young innovators

Sources

[Editor: list the 2–4 primary sources from the research notes for this entry, with the date checked.]

MYCrave · I.N.V.E.N.T. Club

Working on something like this?

Start with a patentability search, not a filing. Request an expert assessment

Part of The MYCrave Young Innovators Index. Last reviewed 31 August 2026. General information, not legal advice.